Mountain View, CA, United States of America

Klaus Klumpp

This inventor holds 1 USPTO granted patent and 1 published patent application and 3 EPO patents. Top assignee: Roche Palo Alto LLC. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Klaus Klumpp. Retrieved from https://idiyas.com/inventor/klaus-klumpp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 66(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Klaus Klumpp: Innovator in Pharmaceutical Research

Introduction

Klaus Klumpp is a notable inventor based in Palo Alto, California. He is currently associated with F. Hoffmann-La Roche AG, a leading global healthcare company. Despite having no patents to his name, his contributions to the field of pharmaceutical research are significant.

Latest Patents

Klaus Klumpp has not registered any patents as of now. However, his work in the industry continues to influence advancements in healthcare and medicine.

Career Highlights

Throughout his career, Klaus has been involved in various projects that focus on innovative solutions in pharmaceuticals. His expertise and dedication to research have made him a valuable asset to his team at F. Hoffmann-La Roche AG.

Collaborations

Klaus has worked alongside talented colleagues such as Joseph Anthony Bilotta and Zhi Chen. Their collaborative efforts contribute to the ongoing success of their projects and the advancement of pharmaceutical research.

Conclusion

Klaus Klumpp is an influential figure in the pharmaceutical industry, contributing to significant advancements despite not holding any patents. His work at F. Hoffmann-La Roche AG and collaborations with esteemed colleagues highlight his commitment to innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…